To Boost Or Not To Boost? Pfizer At Odds With US FDA

Pfizer Unphased By Apparent Pushback

 
• By Andrew McConaghie
  
US vaccination centre
Despite a rapid uptake from some US adults, so far only 54% have received at least one vaccine dose.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip